Challenges in the Regulation of High Cost Treatments: An Overview from Latin America

12:00 pm to 1:00 pm

473 Via Ortega
Y2E2 Building, Room 300 
Stanford, CA  


Patients deserve access to the most effective and safe treatments. At the same time, pharmaceutical companies face high costs in drug development, manufacturing and marketing. In countries where most of the population depends on Public Healthcare Systems, e.g. “SUS” in Brazil, how to ensure accessibility to effective medicines in the context of limited government budgets?

Limited seats - please get tickets prior to attendance at CERSI / UCSF - Stanford 

More information: contact [email protected]